Shares of Sequenom (SQNM +11.1%) pop after the company announces the launch of its MaterniT21 noninvasive prematernal test for Down syndrome. The test is now available in 20 metropolitan cities for expectant women.
Shares of Sequenom (SQNM +11.1%) pop after the company announces the launch of its MaterniT21...
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs